4//SEC Filing
Plavsic Mark 4
Accession 0001193125-25-241622
CIK 0001501796other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 5:44 PM ET
Size
4.8 KB
Accession
0001193125-25-241622
Insider Transaction Report
Form 4
Plavsic Mark
Chief Technology Officer
Transactions
- Sale
Common Stock
2025-10-16$6.35/sh−12,169$77,273→ 197,287 total
Footnotes (1)
- [F1]The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0001868719
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 5:44 PM ET
- Size
- 4.8 KB